Skip to main content
Erschienen in: Digestive Diseases and Sciences 11/2019

16.09.2019 | Multicenter Seminars: IBD (MUSE: IBD)

It’s What’s Up Front That Counts—Part One: Endoscopic Diagnosis and Therapy of Esophageal Crohn’s Disease

verfasst von: Latifat Alli-Akintade, Jennifer Hewitt, Asraa Namiq, Maneesh Singh, Yume Nguyen, Sara Keihanian, Jennifer T. Chang, Sundip Karsan, Samuel Tesfay, Fernando S. Velayos

Erschienen in: Digestive Diseases and Sciences | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Excerpt

A 31-year-old woman initially diagnosed with Crohn’s colitis at age 2 while being assessed for blood diarrhea was evaluated for recurrent dysphagia. …
Literatur
1.
Zurück zum Zitat Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn’s disease. J Gastroenterol Hepatol. 2018;33:355–364.CrossRefPubMed Laube R, Liu K, Schifter M, Yang JL, Suen MK, Leong RW. Oral and upper gastrointestinal Crohn’s disease. J Gastroenterol Hepatol. 2018;33:355–364.CrossRefPubMed
2.
Zurück zum Zitat Crowley E, Muise A. Inflammatory bowel disease: What very early onset disease teaches us. Gastroenterol Clin N Am. 2018;47:755–772.CrossRef Crowley E, Muise A. Inflammatory bowel disease: What very early onset disease teaches us. Gastroenterol Clin N Am. 2018;47:755–772.CrossRef
3.
Zurück zum Zitat De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106–2113.CrossRefPubMed De Felice KM, Katzka DA, Raffals LE. Crohn’s disease of the esophagus: clinical features and treatment outcomes in the biologic era. Inflamm Bowel Dis. 2015;21:2106–2113.CrossRefPubMed
5.
Zurück zum Zitat Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387.CrossRefPubMed Schmitz-Moormann P, Malchow H, Pittner PM. Endoscopic and bioptic study of the upper gastrointestinal tract in Crohn’s disease patients. Pathol Res Pract. 1985;179:377–387.CrossRefPubMed
6.
Zurück zum Zitat Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.CrossRefPubMedPubMedCentral Wang W, Ni Y, Ke C, Cheng Q, Lu Q, Li X. Isolated Crohn’s disease of the esophagus with esophago-mediastinal fistula formation. World J Surg Oncol. 2012;10:208.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bonavina L, Bettineschi F, Cecchetto A, Pomerri F. Crohn’s disease of the esophagus. Dysphagia. 1989;4:176–179.CrossRefPubMed Bonavina L, Bettineschi F, Cecchetto A, Pomerri F. Crohn’s disease of the esophagus. Dysphagia. 1989;4:176–179.CrossRefPubMed
8.
Zurück zum Zitat Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11:3–25.CrossRef Gomollon F, Dignass A, Annese V, et al. 3rd European evidence-based consensus on the diagnosis and management of Crohn’s disease 2016: part 1: diagnosis and medical management. J Crohn’s Colitis. 2017;11:3–25.CrossRef
9.
Zurück zum Zitat Grassia R, Staiano T, Buffoli F, Paolo B. Severe esophageal Crohn’s disease: healing of lesions after 1 week therapy with infliximab. J Crohn’s Colitis. 2009;3:138–139.CrossRef Grassia R, Staiano T, Buffoli F, Paolo B. Severe esophageal Crohn’s disease: healing of lesions after 1 week therapy with infliximab. J Crohn’s Colitis. 2009;3:138–139.CrossRef
10.
Zurück zum Zitat Kwan LY, Conklin JL, Papadakis KA. Esophageal Crohn’s disease treated successfully with adalimumab. Inflamm Bowel Dis. 2007;13:639–640.CrossRefPubMed Kwan LY, Conklin JL, Papadakis KA. Esophageal Crohn’s disease treated successfully with adalimumab. Inflamm Bowel Dis. 2007;13:639–640.CrossRefPubMed
12.
Zurück zum Zitat Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC. Tofacitinib for the treatment of tumor necrosis factor-alpha inhibitor refractory esophageal Crohn’s disease: a case report. J Med Case Rep. 2016;10:264.CrossRefPubMedPubMedCentral Nathoo S, Hood WA, Keihanian S, Collinsworth AL, Glover SC. Tofacitinib for the treatment of tumor necrosis factor-alpha inhibitor refractory esophageal Crohn’s disease: a case report. J Med Case Rep. 2016;10:264.CrossRefPubMedPubMedCentral
Metadaten
Titel
It’s What’s Up Front That Counts—Part One: Endoscopic Diagnosis and Therapy of Esophageal Crohn’s Disease
verfasst von
Latifat Alli-Akintade
Jennifer Hewitt
Asraa Namiq
Maneesh Singh
Yume Nguyen
Sara Keihanian
Jennifer T. Chang
Sundip Karsan
Samuel Tesfay
Fernando S. Velayos
Publikationsdatum
16.09.2019
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 11/2019
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-019-05833-x

Weitere Artikel der Ausgabe 11/2019

Digestive Diseases and Sciences 11/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.